These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33703881)

  • 61. Probiotic properties of yeasts in traditional fermented foods and beverages.
    Tamang JP; Lama S
    J Appl Microbiol; 2022 May; 132(5):3533-3542. PubMed ID: 35094453
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.
    Ochangco HS; Gamero A; Smith IM; Christensen JE; Jespersen L; Arneborg N
    World J Microbiol Biotechnol; 2016 Sep; 32(9):141. PubMed ID: 27430508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro.
    Smith IM; Baker A; Christensen JE; Boekhout T; Frøkiær H; Arneborg N; Jespersen L
    PLoS One; 2016; 11(11):e0167410. PubMed ID: 27898740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Tunable and Expandable Transactivation System in Probiotic Yeast
    Kwak S; Mahmud B; Dantas G
    ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of yeast probiotic
    Nikaein D; Malekmadani H; Beikzadeh B; Mardanpour R; Khosravi A; Moghadami SM
    Curr Med Mycol; 2023 Dec; 9(4):1-8. PubMed ID: 38983617
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of probiotic Saccharomyces boulardii in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Oliveira FMS; Caliari MV; Martins FS; Nicoli JR; Torres MF; Andrade MER; Cardoso VN; Gomes MA
    Benef Microbes; 2018 Sep; 9(5):789-797. PubMed ID: 30165752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Probiotic Yeasts: A Developing Reality?
    Tullio V
    J Fungi (Basel); 2024 Jul; 10(7):. PubMed ID: 39057374
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
    Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
    Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Recent advances in Saccharomyces boulardii research].
    Im E; Pothoulakis C
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S62-70. PubMed ID: 20889007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.
    Dahan S; Dalmasso G; Imbert V; Peyron JF; Rampal P; Czerucka D
    Infect Immun; 2003 Feb; 71(2):766-73. PubMed ID: 12540556
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice.
    Filho-Lima JV; Vieira EC; Nicoli JR
    J Appl Microbiol; 2000 Mar; 88(3):365-70. PubMed ID: 10747216
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protective effect of the probiotic Saccharomyces boulardii in Toxocara canis infection is not due to direct action on the larvae.
    Avila LF; Telmo Pde L; Martins LH; Glaeser TA; Conceição FR; Leite FP; Scaini CJ
    Rev Inst Med Trop Sao Paulo; 2013; 55(5):363-5. PubMed ID: 24037293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
    Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
    Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of In Vitro
    Lacotte PA; Simons A; Bouttier S; Malet-Villemagne J; Nicolas V; Janoir C
    Microorganisms; 2022 May; 10(6):. PubMed ID: 35744599
    [No Abstract]   [Full Text] [Related]  

  • 75. Probiotic and Potentially Probiotic Yeasts-Characteristics and Food Application.
    Staniszewski A; Kordowska-Wiater M
    Foods; 2021 Jun; 10(6):. PubMed ID: 34200217
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Influence of different timing of
    He CX; Kong FT; Liang F; Wang KX; Li H; Liu YL; Zhao W; Zhou PP; Kong FL
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1731-1734. PubMed ID: 31216821
    [No Abstract]   [Full Text] [Related]  

  • 77. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
    Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
    Dinleyici EC; Kara A; Dalgic N; Kurugol Z; Arica V; Metin O; Temur E; Turel O; Guven S; Yasa O; Bulut S; Tanir G; Yazar AS; Karbuz A; Sancar M; Erguven M; Akca G; Eren M; Ozen M; Vandenplas Y
    Benef Microbes; 2015; 6(4):415-21. PubMed ID: 25653151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The probiotic effect of Saccharomyces boulardii in a pediatric age group.
    Erdeve O; Tiras U; Dallar Y
    J Trop Pediatr; 2004 Aug; 50(4):234-6. PubMed ID: 15357564
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Saccharomyces boulardii in childhood.
    Vandenplas Y; Brunser O; Szajewska H
    Eur J Pediatr; 2009 Mar; 168(3):253-65. PubMed ID: 19096876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.